The COVID-19 pandemic: A community approach

Paolo Cravedi; Jesse D Schold; Kassem Safa; Olivia S Kates; Nissreen Elfadawy; Roslyn B Mannon; Malay B Shah; Sarah P Hammond; Robin Avery; Cesar Guerrero Miranda; Leonardo V Riella; Sheila Jowsey-Gregoire; Enver Akalin; Geoffrey Camirand; Maria-Luisa Alegre; Jamil Azzi

doi:10.1111/ctr.14059

The COVID-19 pandemic: A community approach

Clin Transplant. 2020 Nov;34(11):e14059. doi: 10.1111/ctr.14059. Epub 2020 Sep 28.

Authors

Paolo Cravedi¹, Jesse D Schold², Kassem Safa³, Olivia S Kates⁴, Nissreen Elfadawy⁵, Roslyn B Mannon⁶, Malay B Shah⁷, Sarah P Hammond⁸, Robin Avery⁹, Cesar Guerrero Miranda¹⁰, Leonardo V Riella¹¹, Sheila Jowsey-Gregoire¹², Enver Akalin¹³, Geoffrey Camirand¹⁴, Maria-Luisa Alegre¹⁵, Jamil Azzi¹¹

Affiliations

¹ Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
² Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
³ Transplant Center and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
⁵ Division of Nephrology, Hypertension and Kidney Transplant, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, OH, USA.
⁶ Division of Nephrology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
⁷ Division of Transplantation, Department of Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
⁸ Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁹ Division of Infectious Diseases, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
¹⁰ Baylor Scott and White Heart and Vascular Hospital, Dallas, TX, USA.
¹¹ Transplanation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
¹² Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
¹³ Albert Einstein College of Medicine, Montefiore Medical Center, New York City, NY, USA.
¹⁴ The Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical, Pittsburgh, PA, USA.
¹⁵ Department of Medicine, University of Chicago, Chicago, IL, USA.

Abstract

An unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community "Outstanding Questions in Transplantation," hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature.

Keywords: immune deficiency; immunosuppressant; infection and infectious agents.

Publication types

Review

MeSH terms

COVID-19* / epidemiology
COVID-19* / immunology
COVID-19* / therapy
Global Health
Graft Rejection / prevention & control
Humans
Immunocompromised Host
Immunosuppressive Agents / therapeutic use
International Cooperation
Organ Transplantation*
Pandemics*
Postoperative Complications* / epidemiology
Postoperative Complications* / immunology
Postoperative Complications* / therapy
SARS-CoV-2*
Societies, Medical

Substances

Immunosuppressive Agents

Abstract

Publication types

MeSH terms

Substances

Grants and funding